Vivesto established a comprehensive patent protection strategy for medicines formulated with XR-17™ that is independent of the API used.
Vivesto pursues an aggressive strategy of continuously expanding its Intellectual Property in many jurisdictions around the world.
Current patent families of interest
| Family name | Scope summary |
| Taxol containing compositions. | XR-17 compound precursors |
| Anticancer compositions | XR-17 compounds |
| Water insoluble | Water insoluble API formulated with XR-17. |
| Water soluble | Water soluble API formulated with XR-17. |
| Tax-Dox-Mix | More than one APIs formulated with XR-17
(In US, one or more) |
| XMeNa process | Improved process for production of XR-17 component XMeNa |
Disclaimer: The above represents an overview of the portfolio. Detailed information on granted patents and published applications is available from official sources at the patent offices in question.